Notices of this kind (Romania, open procedure, above the EU threshold) give a median of 33 days, half of them between 22 and 35 days, based on 15,778 notices of the last two years.
Fewer days than three in four comparable notices. Check the documents early and ask questions before the clarification deadline.
This buyer usually gives 30 days (median of its last 19 calls for tender).
Romania - Various medicines - Antineoplastics, analgesics, antihemorrhagics, other medicines - 99 lots - 2026 (3)
Buyer: Spitalul Clinic de Urgenta pentru Copii Cluj-Napoca
Country: Romania
Deadline: 26 Oct 2026, 15:00 (UTC+2)
Estimated value: €1,471,253
Procedure: Open procedure
Sector (CPV): Medical equipment & pharmaceuticals (33690000)
Aperlena: https://aperlena.com/en/t/romania-diverse-medicamente-antineoplazice-analgezice-antihemoragice-diverse-medicamente-99-loturi-2026-3-97a3c2d1c0
Official notice: https://ted.europa.eu/en/notice/-/detail/693090-2026
If the deadline moves or the notice is corrected, we email you.
Log in
The Aperlena Verdict
Open race
No supplier dominates: 9 different companies have won the last 9 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 9 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice.
How we score ourselves.
01
Summary
Machine-generated summary
The tender aims to conclude framework agreements for supplying medicines to hospitalised patients in a hospital. The quantities, estimated values and list of requested medicines are given in the table in the award documentation, Annex 1. Contracts will be awarded through 24 successive contracts depending on budget allocations and the needs of hospital departments, with an estimated minimum and maximum shown per medicine, including cytotoxic and oncology products such as cytarabine, rituximab, dactinomycin, cisplatin, dasatinib, deferasirox, eptacog alfa activated (NovoSeven) and coagulation factor VIII with von Willebrand factor (Immunate). Framework agreements run for 24 months, extendable by up to 12 months. Lot 17, for spinal muscular atrophy under the rare diseases programme, has a 12 month duration and will be awarded to two economic operators.
02
Description
Incheierea unor Acorduri-Cadru de furnizare medicamente pentru pacientii internati in cadrul spitalului. Toate detaliile legate de valori si cantitati estimate se regasesc in tabelul din caietul de sarcini / Anexa 1 - Lista medicamentelor solicitate. Frecventa contractelor ce urmeaza sa fie atribuite: 24 contracte subsecvente, in functie de alocarile bugetare si necesarul sectiilor. Durata acordurilor-cadru va fi de 24 luni, perioadă ce poate fi prelungită prin act-adițional, cu acordul părților, cu maxim 12 luni, conform art. 221 alin. 1, litera a), Lg. 98/2016. Exceptie facand produsul inclus în Programul Național de diagnostic și tratament pentru boli rare și sepsis sever - Amiotrofia spinală musculară, lotul 17, atribuirea se va realiza prin încheierea unui acord-cadru cu doi operatori economici, pentru o perioadă de 12 luni. Achizitorul isi rezerva dreptul de a denunta unilateral acordul-cadru, printr-o notificare scrisa, fara nici o compensatie, de la data incheierii acordurilor-cadru de către Ministerul Sanatatii, in calitate de unitate centralizata de achizitii. Termenul limita de solicitare clarificari este de 18 zile inainte de data limita de depunere a ofertelor/candidaturilor. Raspunsul clar si complet va fi transmis cu cel putin 10 zile inainte de data limita de depunere a ofertelor.
CYTARABINUM sol. Inj./perf. 42/126; 800/1000; RITUXIMAB conc.pt.sol.perf. 6/18; 120/150; DACTINOMICINUM pulb. pt. sol. inj. 10/30; 200/250; CISPLATINUM conc. pt. sol. perf. 4/12; 80/100; DASATINIBUM COMPR. FILM. 85/255; 1632/2040; DASATINIBUM COMPR. FILM. 84/252; 1608/2010; DEFERASIROXUM cpr. film. 125/375; 2400/3000; DEFERASIROXUM cpr. film. 88/264; 1680/2100; EPTACOG ALFA ACTIVATUM 50 KUI ( NOVOSEVEN) PULB.+SOLV. PT. SOL. INJ. 13/39; 240/300; FACTOR VIII DE COAGULARE 1000UI FVIII SI FACTOR VON WILLEBRAND 750 UI FVW(IMMUNATE) pulv+solv. Sol. Inj 4/12; 80/100; FACTOR VIII DE COAGULARE 500UI SI FACTOR VON WILLEBRAND 375 UI FVW (IMMUNATE) pulv+solv. Sol. Inj 4/12; 80/100; ELTROMBOPAG cpr. film. 257/771; 4928/6160; OXIHIDROXID SUCROFERIC COMPR. MAST. 563/1689; 10800/13500; SEVELAMER cpr 563/1689; 10800/13500; CINACALCETUM cpr. film. 84/252; 1612.8/2016; NUSINERSENUM SOL. INJ. 1/2; 1/3; ACICLOVIRUM COMPR. 83/249; 1600/2000; ACIDUM FOLICUM cpr. film. 125/375; 2400/3000; ALBUMINUM HUMANUM sol. perfuzabila 250/750; 4800/6000; AMIODARONUM conc. pt. sol. inj./perf. 9/27; 176/220; AMOXICILLINUM + ACIDUM CLAVULANICUM Compr. Film. 58/174; 1120/1400; APA DE MARE ECHIV. QUIXX spray nazal 42/126; 800/1000; ARIPIPRAZOLUM cpr. Orodisp. 146/438; 2800/3500; ATRACURIUM sol.inj.perf. 29/87; 560/700; ATROPINUM sol inj 125/375; 2400/3000; AZITHROMYCINUM compr. film. 50/150; 960/1200; AZITHROMYCINUM compr. film. 38/114; 720/900; AZITHROMYCINUM 20ML pulb. pt. susp. Orala 75/225; 1440/1800; BRIVARACETAMUM sol.orala 4/12; 80/100; CALCII LACTAS cpr 208/624; 4000/5000; CEFUROXIMUM gran.pt susp.orala 50/150; 960/1200; CEFUROXIMUM cpr. film. 42/126; 800/1000; CIPROFLOXACINUM pic.oftalmologice/auriculare, sol 21/63; 400/500; COMBINATII (CEFOPERAZONUM+SULBACTAMUM) pulb.sol.inj/perf. 42/126; 800/1000; COMBINATII (NEOMYCINUM+DEXAMETHASONUM+POLIMYXYNUM) PICATURI OFT., SUSP. 208/624; 4000/5000; COMBINATII (PANTHENOL 5%, ECHIV. BEPANTHEN) unguent 29/87; 560/700; COMBINATII (TRIAMCINOLONUM + NEOMICINUM + NYSTATINUM) crema 100/300; 1920/2400; COMBINATII (BACITRACINUM+NEOMYCINUM) unguent 63/189; 1200/1500; COMBINATII VITAMINA B COMPLEX SIROP, DOAR CU AUTORIZATIE ANMDMR-NU SUPLIMENT ALIMENTAR sirop 33/99; 640/800; "Combinatii WELLBABY sau echivalent (Vitamina C 30 MG,Vitamina B3/niacina 6mg, Vitamina E 5mg,,Citrat de amoniu feric 4mg, sulfat de zinc 2,5mg, acid pantotenic/D-panthenol 2mg, Vitamina B2/ 0,8mg,Vitamina B1 0,5mg, Vitamina B6 0,5mg, sulfat de cupru heptahidrat 150mcg, Vitamina A palmitat 133mcg, acid folic 80mcg,Vitamina D3/colecalciferol 10 mcg, Vitamina B12/ciancobalamina 1mcg,ulei de masline, sorbat de potasiu, zahar din trestie de zahar, hidroxid de sodiu, acid citric monohidrat, extract din malt de orz, apa purificata per 5ml sirop 83/249; 1600/2000"; Combinatii(Picosulfat de sodiu 10mg ,Oxid de magneziu usor 3,5g ,Acid citric anhidru 12g) pulb. pt. sol. orala 25/75; 480/600; CYANOCOBALAMINUM sol. Inj. 83/249; 1600/2000; DEXAMETHASONUM cpr 292/876; 5600/7000; DIOSMECTITA pulb. pt susp. orala 125/375; 2400/3000; ENOXAPARINUM sol inj 125/375; 2400/3000; EPHEDRINI HYDROCHLORIDUM sol inj 4/12; 80/100; FLUTICASONUM PROPIONAT suspensie de inhalat prin nebulizator 1042/3126; 20000/25000; GADOBUTROLUM sol inj 42/126; 800/1000; GINKGO BILOBA picaturi orale, sol. 4/12; 80/100; GLUCAGONUM pulbere nazala unidoza 2/6; 32/40; GLUCOSUM 5% sol perf 667/2001; 12800/16000; HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA sol.inj./conc. pt. sol. perf. 13/39; 240/300; HYDROCORTISONUM sol. Inj. 2083/6249; 40000/50000; IBUPROFENUM compr. film. 500/1500; 9600/12000; IMIPENEMUM + CILASTATATINUM pulbere pt sol perf. 167/501; 3200/4000; IOHEXOLUM sol. inj. 42/126; 800/1000; KANAMYCINUM UNG. OFT. 13/39; 240/300; KETOROLACUM TROMETHAMIN sol. Inj. 313/939; 6000/7500; LACTOBACILLUS REUTERI DSM 17938-PROTECTIS picaturi 50/150; 960/1200; LACTULOSUM solutie orala 29/87; 560/700; LEVETIRACETAMUM cpr. film. 125/375; 2400/3000; LEVETIRACETAMUM cpr. film. 25/75; 480/600; LEVOCARNITINUM solutie orala 167/501; 3200/4000; LEVOMEPROMAZINUM cpr 150/450; 2880/3600; MACROGOLUM 10 G pulb.pt.sol.orala 63/189; 1200/1500; METHYLPREDNISOLONUM PULB. + FL SOLV. PT SOL INJ./ PERF. 42/126; 800/1000; METOCLOPRAMIDUM sirop 5/15; 96/120; METOPROLOLUM cpr. 125/375; 2400/3000; MORPHYNUM sol inj 33/99; 640/800; NATRII CHLORIDUM 5,85% CONC. PT. SOL. PERF. 417/1251; 8000/10000; NATRII HYDROGENI CARBONAS CONC. PT. SOL. PERF. 208/624; 4000/5000; OCTREOTIDUM sol inj/perf. 50/150; 960/1200; OCTREOTIDUM pulb. si solv. pt. susp. inj. 1/3; 28/35; OXELADINUM sirop 13/39; 240/300; PANCREATINUM( KREON 10000) caps gastrorez. 333/999; 6400/8000; PARACETAMOLUM cpr 500/1500; 9600/12000; PHENYTOINUM sol. Inj. 21/63; 400/500; PIPERACILLINUM + TAZOBACTAMUM pulb.pt.sol.perf. 417/1251; 8000/10000; PYRIDOXINUM sol inj. 208/624; 4000/5000; RETINOLUM picaturi orale, sol. 21/63; 400/500; RISPERIDONUM cpr. film. 125/375; 2400/3000; RISPERIDONUM sol. orala 17/51; 320/400; RITUXIMAB conc.pt.sol.perf. 4/12; 80/100; SALBUTAMOLUM sol. de inhal. prin nebulizator 625/1875; 12000/15000; SUXAMETHONII CHLORIDUM sol inj 27/81; 520/650; TEICOPLANINUM PULB.+SOLV. PT. SOL. INJ./PERF. SAU SOL. ORALA 250/750; 4800/6000; TRIHEXYPHENIDYLUM compr. 146/438; 2800/3500; VACC PNEUMOCOCIC POLIZAHARIDIC CONJ. 13- VALENT ADS. susp. inj. in seringa preumpluta 1/3; 8/10; VACC PNEUMOCOCIC POLIZAHARIDIC CONJ. 20-VALENT ADS susp. inj. in seringa preumpluta 1/3; 8/10; VANCOMYCINUM pulb.pt.sol.perf. 208/624; 4000/5000; MAGNESII SULFAS sol inj./perf. 292/876; 5600/7000; MESALAZINUM compr. gastrorez. 208/624; 4000/5000; OMEPRAZOLUM conc. si solv. pt. sol. orala 58/174; 1120/1400; TOPIRAMATUM cpr film. 125/375; 2400/3000; TOPIRAMATUM cpr film. 167/501; 3200/4000; FLUCONAZOLUM SOL. PERF. 83/249; 1600/2000
03
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
likely award for this notice, from its published estimate of €1,471,253
€1.4M to €1.5M
Comparable awards in this country and sector came in at a median of 99% of their published estimate, half of them between 94% and 100%, based on 214 awards of the last 3 years.
Each award is compared with the estimate of the same lots, framework agreements excluded. A published estimate may include options and renewals, so an award under it is not always a discount.
05
What this market pays
The buyer has too few awards of its own in this sector, so this is the range of the last 2,000 awards for Medical equipment & pharmaceuticals in Romania.
€104€56.7M
This notice
€1.5M
Median award
€186,142
Middle half of past awards
€50,947 to €701,364
The estimate is larger than three in four past awards.
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Spitalul Clinic de Urgenta pentru Copii Cluj-Napoca
Romania
notices in the register
36
awards
17
awarded in total
€422,879
Who wins its contracts
Many suppliers
different companies won its awards
16
of the awards went to the three most frequent winners
24%
of its calls state an estimated value
42%
Based on 17 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable.
Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
tenders per lot on average (open and restricted procedures)
1.9
of those lots received a single tender
41%
of the awards went to companies based in another country
0%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Romania
Larger than 83% of the open notices in Medical equipment & pharmaceuticals across Europe.
smallestlargest
open now in Medical equipment & pharmaceuticals
11,274
median open notice
€140,000
Who wins in this market
Many suppliers
Romania · Medical equipment & pharmaceuticals
different companies won awards here
6,836
of the awards went to the three most frequent winners
2%
buyers awarded contracts here
482
Based on 9,915 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable.
Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
tenders per lot on average (open and restricted procedures)
2.2
of those lots received a single tender
28%
of the awards went to companies based in another country
1%
of the tenders came from another country
4%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.